ABSTRACT
In this study, 232 class I Newcastle disease viruses (NDVs) were identified from multiple bird species at nationwide live bird markets (LBMs) from 2017 to 2019 in China. Phylogenetic analysis indicated that all 232 isolates were clustered into genotype 1.1.2 of class I on the basis of the fusion (F) gene sequences, which were distinct from the genotypes identified in other countries. Most of the isolates (212/232) were shown to have the typical F gene molecular characteristics of class I NDVs, while a few (20/232) contained mutations at the site of the conventional start codon of the F gene, which resulted in open reading frames (ORFs) altered in length. The isolates with ACG, CTA, and ATA mutations showed different levels of increased virulence and replication capacity, suggesting that these viruses may be transitional types during the evolution of class I NDVs from avirulent to virulent. Further evaluation of biological characteristics with recombinant viruses obtained by reverse genetics demonstrated that the ATG located at genomic positions 4523 to 4525 was the authentic start codon in the F gene of class I NDV, and the specific ATA mutations which contributed to the expression of F protein on the surface of infected cells were the key determinants of increased replication capacity and virulence. Interestingly, the mutation at the corresponding site of genotype II LaSota of class II had no effects on the virulence and replication capacity in chickens. Our results suggest that the alteration of virulence and replication capacity caused by specific mutations in the F gene could be a specific characteristic of class I NDVs and indicate the possibility of the emergence of virulent NDVs due to the persistent circulation of class I NDVs.
IMPORTANCE The available information on the distribution, genetic diversity, evolution, and biological characteristics of class I Newcastle disease viruses (NDVs) in domestic poultry is currently very limited. Here, identification of class I NDVs at nationwide live bird markets (LBMs) in China was performed and representative isolates were characterized. A widespread distribution of genotype 1.1.2 of class I NDVs was found in multiple bird species at LBMs in China. Though most isolates demonstrated typical molecular characteristics of class I NDVs, a few that contained specific mutations at the site of the conventional start codon of the fusion gene with increased virulence and replication capacity were identified for the first time. Our findings indicate that the virulence of class I NDVs could have evolved, and the widespread transmission and circulation of class I NDVs may represent a potential threat for disease outbreaks in poultry.
KEYWORDS: Newcastle disease virus, class I, fusion gene, start codon, mutation
INTRODUCTION
Avian orthoavulavirus 1, commonly known as Newcastle disease virus (NDV), is a member of the genus Orthoavulavirus in the family Paramyxoviridae (1). Since the first description in 1926, numerous NDV isolates belonging to distinct genetic groups have been identified worldwide (2). The recent classification system based on the phylogenetic analysis of the complete fusion (F) gene coding sequence classifies NDVs into two distinct classes, class I and class II, within a single serotype (3–5). Class II NDVs show high genetic diversity and are further classified into 20 defined genotypes. In contrast, class I NDVs are less diverse, and all isolates are classified into one genotype with three subgenotypes (1.1.1, 1.1.2, and 1.2) (3).
Class II NDVs contain a range of avirulent to virulent strains that have been identified in multiple wild bird and domestic poultry species. The majority of the class II viruses are virulent and responsible for most of the disease outbreaks worldwide (6, 7). However, class I NDVs are primarily isolated from wild birds (waterfowl and shorebirds) and live bird markets (LBMs) in most cases (8–10). To our knowledge, all class I NDVs have been identified as avirulent strains, except for one virulent strain, which was reported in Ireland in 1990 (11, 12). In recent years, the isolation of virulent class II NDVs has been infrequently reported in China due to the intensive and strict vaccination policy (13). In contrast, increasing numbers of class I viruses have been isolated from wild birds and domestic poultry (ducks, chickens, and pigeons) (13–20) since the first identification of class I viruses in domestic ducks at LBMs in 2002 in China (15), although most of the viruses were isolated from samples collected at LBMs. However, the available information on the geographic distribution, genetic diversity, evolution, and biological characteristics of class I NDVs is very limited.
It is well known that the virulence of NDV is determined by multiple genetic factors (21). The contributions of the viral replication complex, the envelope-associated F and hemagglutinin-neuraminidase (HN) proteins, and the interferon-antagonistic activities of the nonstructural V protein are factors found to contribute to the virulence of NDV (22–29). Of these factors, the F protein is identified as the major individual contributor (30). Although it is believed that the amino acid motif at the F protein cleavage site is the primary determinant of virulence, accumulating evidence suggests that the contribution of the F protein to virulence is not exclusively dependent on the cleavage site (27, 30). For instance, the alteration of specific amino acids in the signal peptide region of the F protein in combination with a specific amino acid substitution in the HN protein increased the virulence of NDV (31). In addition, altered virulence was also achieved by exchanging the heterologous F2 containing the signal peptide region (32). These findings indicate that specific amino acids or domains in the F protein are also responsible for the virulence of NDV.
In most cases, avirulent NDVs, including those belonging to class I strains, do not cause clinical disease in birds; however, concerns still exist regarding the potential of avirulent NDVs to undergo an increase in virulence. The outbreaks in Ireland in 1990 and in Australia between 1998 and 2000 were believed to be caused by a class I variant and a class II genotype I variant, respectively (11, 33). Moreover, it has been demonstrated that the virulence of avirulent class I NDVs can increase via passage in birds (34, 35).
In this study, a large number of class I NDVs were molecularly identified. In order to fully investigate the genetic diversity of these viruses and evaluate the potential of avirulent NDV strains to become virulent, the molecular and biological characteristics of the representative isolates and the contribution of specific mutations at the site of the conventional start codon in the F gene to the virulence and replication capacity of class I NDVs were investigated.
RESULTS
Class I NDVs were isolated from different poultry species and environments at nationwide LBMs in China.
In this study, 232 NDV isolates were identified and classified in class I. These isolates were collected from LBMs in China from 2017 to 2019. Of the 232 isolates, 101 were obtained from 13 provinces/municipalities in 2017, 70 were obtained from 14 provinces/municipalities in 2018, and 61 were obtained from 13 provinces/municipalities in 2019 (Fig. 1A). Of the 101 isolates obtained in 2017, 64 (63.37%) were isolated from chickens, 10 (9.90%) from ducks, 25 (24.75%) from the environment, 1 (0.99%) from pigeons, and 1 (0.99%) from geese. Of the 70 isolates obtained in 2018, 47 (67.14%) were isolated from chickens, 12 (17.14%) from ducks, 8 (11.43%) from the environment, and 3 (4.29%) from pigeons. Of the 61 isolates obtained in 2019, 41 (67.21%) were isolated from chickens, 17 (27.87%) from ducks, and 3 (4.92%) from the environment (Fig. 1B). Detailed information of the 232 class I NDVs is shown in Table S1 in the supplemental material. Our results reported the wide distribution of class I NDVs in different poultry species and environments at nationwide LBMs in China.
FIG 1.
Distribution of 232 class I NDVs isolated from LBMs in China from 2017 to 2019. (A) Geographical locations of provinces or municipalities from where class I NDVs were isolated from 2017 to 2019. (B) Isolation of class I NDVs from different hosts.
Molecular characteristics of the F gene of class I NDVs.
The complete F genes of all 232 class I NDVs were sequenced. The annotation of potential open reading frames (ORFs) in the F gene indicated that most of the isolates (212/232) had the classical ORF, which was 1662 nucleotides (nt) in length (ORF-1662), in which the start codon (ATG) and terminal codon (TAA) were located at genomic positions 4556 to 4558 (ATG/4556-4558) and 6215 to 6217, respectively. Two additional ORFs were found in the F gene of most viruses, with the ATG codon located at genomic positions 4523 to 4525 (ATG/4523-4525) and 4544 to 4546 (ATG/4544-4546) and with the same TAA codon as that of ORF-1662, resulting in another two potential ORFs with lengths of 1695 nt (ORF-1695) and 1674 nt (ORF-1674). In total, 152 isolates (65.51%) had ORF-1662, ORF-1674, and ORF-1695; 54 isolates (23.28%) had ORF-1662 and ORF-1695; and 6 isolates (2.59%) had ORF-1662 and ORF-1674 (Fig. 2A, panel a). Interestingly, mutations were found in ATG/4556-4558 in 20 of the 232 isolates (8.62%), which resulted in the absence of the classical ORF-1662 but the presence of ORF-1695 and ORF-1674 (Fig. 2A, panel a). These 20 NDV isolates were obtained from different regions and hosts in China (Table S1).
FIG 2.
Molecular characteristics of the F gene of class I NDVs. (A) (a) Predicted ORF in the F gene of the 232 class I NDVs. The number and ratio of isolates that contained the corresponding types of ORF are shown. (b) Type, number, and percentage of codons at genomic positions 4523 to 4525, 4544 to 4546, and 4556 to 4558 of 232 class I NDVs which are responsible for the potential ORFs. (B) (a) Predicted amino acid sequence alignment of the F protein from the 232 class I NDVs and other representative class I isolates (genotype 1.1.2 isolate, FJ027; genotype 1.1.1 isolate, NDV08-004; genotype 1.2 isolate, NDV08-046). The amino acid sequence of the F protein was deduced from ORF-1695. The signal peptide, the determinant amino acids of the neutralizing epitopes, potential N-glycosylation sites, the cleavage site, and the heptad repeat regions are indicated. (b) Type, number, and percentage of amino acids at the cleavage site of the F protein from the 232 class I NDVs. (c) Ratio of different cleavage site motifs of the F protein among the 232 class I NDVs.
Further sequence analysis found that there were different types of mutations at the ATG/4523-4525, ATG/4544-4546, and ATG/4556-4558 start codons compared with other viruses. As shown in Fig. 2A, panel b, and Table S1, three types of codons were found at genomic positions 4523 to 4525, in which 226 (97.41%) isolates had ATG, 4 (1.72%) had ACG, and 2 (0.86%) had ATA. Four types of codons were found at genomic positions 4544 to 4546, in which 178 (76.72%) isolates had codon ATG, 31 (13.36%) had GTG, 22 (9.48%) had ATA, and 1 (0.43%) had ACG. Four types of codons were found at genomic positions 4556 to 4558, in which 212 (91.38%), 7 (3.02%), 7 (3.02%), and 6 (2.59%) of the isolates had ATG, ATA, CTA, and ACG, respectively. For the seven isolates with ATA at genomic positions 4556 to 4558, one, two, and four isolates were obtained from chickens, ducks, and the environment, respectively. For the seven isolates with CTA at genomic positions 4556 to 4558, four, one, and two isolates were obtained from chickens, ducks, and the environment, respectively. For the six isolates with ACG at positions 4556 to 4558, five and one isolates were obtained from chickens and pigeons, respectively. Thus, no obvious host preference was observed for these isolates with mutations at positions 4556 to 4558.
The comparative analysis of the deduced amino acid sequences of the F protein was further performed with our 232 class I isolates and representative strains of different genotypes, including Du/CH/LFJ/027/2011 (FJ027) (genotype 1.1.2), NDV08-004 (genotype 1.1.1), and NDV08-046 (genotype 1.2) (3, 17). As shown in Fig. 2B, panel a, the major functional domains of the F protein, including the fusion peptide, the potential N-glycosylation sites, the determinant amino acids of the neutralizing epitopes (36, 37), and the heptad repeat regions (38), were highly conserved among all class I NDVs. In the signal peptide, the amino acids at positions 3 and 40 in the F protein were conserved among all viruses; however, amino acid substitutions were found at the remaining positions. In addition, at the cleavage site motif of the F protein, amino acid substitutions were found at positions 123, 124, and 126 (Fig. 2B, panel b). Of the 232 class I NDV isolates, 197 (84.91%) had the cleavage site motif ERQERL and 22 (9.48%), 5 (2.16%), 4 (1.72%), 1 (0.43%), 1 (0.43%), and 2 (0.86%) had the motifs ERQGRL, GRQERL, EQQERL, ERQDRL, GRQDRL, and KRQERL, respectively (Fig. 2B, panel c).
The class I NDVs isolated in China are genetically closely related.
To investigate the phylogenetic relationship of the class I NDVs isolated in China and other countries, a phylogenetic tree was constructed with the maximum-likelihood method based on the complete coding region of the F gene from our 232 NDVs and 284 reference class I NDVs (3). As shown in Fig. 3A, panel a, our 232 isolates and 138 reference NDVs isolated in China formed genotype 1.1.2, the largest cluster in the phylogenetic tree. Moreover, 109 and 28 isolates were grouped into genotypes 1.2 and 1.1.1, respectively. In addition, 2 isolates from China and 1 strain from the United States were grouped into the genotype 1.1 branch but without classification into the defined subgenotypes. Of note, all isolates which were grouped into genotypes 1.1.1 (n = 28; 5.43%) and 1.1.2 (n = 370; 71.71%) were isolated from China. The 109 genotype 1.2 NDVs were from different countries worldwide (Fig. 3A, panel b).
FIG 3.
Phylogenetic analysis of class I NDVs in China. (A) (a) F gene coding sequences (ORF-1662) of 232 class I NDV strains identified in this study combined with the class I F gene data set established by Dimitrov et al. were used for the phylogenetic analysis (3). On the basis of the F gene ORF-1662, the phylogenetic tree was constructed with MEGA X software using maximum likelihood with 1,000 bootstraps (71). The number and percentage of the isolates which were classified into the specific genotype are shown. (b) Number and percentage of the isolates of specific genotypes reported in different countries. (B) Numbers of class I isolates of different genotypes reported in China since 2002.
In China, the first class I NDV strain was isolated from domestic ducks at LBMs in 2002 (15), and was assigned to genotype 1.2 based on the recent classification system (Fig. 3B). Thereafter, isolates of genotypes 1.1.1 and 1.2 were continuously identified between 2005 and 2008 in China. Genotype 1.1.2 NDVs were first described in 2009. Since then, the number of genotype 1.1.2 isolates has gradually increased in China, and this genotype became the predominant genotype as of 2016 (Fig. 3B). Phylogenetic analysis demonstrated that the class I strains isolated in China are genetically closely related to each other and have evolved into independent branches (Fig. S1). In general, class I strains isolated in China were distinct from the strains isolated in other countries.
Unique nucleotide substitutions are found in subgenotypes of class I NDVs.
It has been suggested that all class I NDVs could be rooted to an oldest isolate, Canada goose/US(OH)/87-78/1987, which was isolated from a Canada goose in 1987 in the United States (3, 8). In this study, our results showed that the Canada goose/US(OH)/87-78/1987 strain shared 96.2 to 98.7%, 93.2 to 94.5%, and 92.5 to 94.8% nucleotide identities with strains of genotypes 1.2, 1.1.1, and 1.1.2, respectively, on the basis of the nucleotide identities of the F gene coding sequence (genomic positions 4556 to 6217). Importantly, multiple unique nucleotide substitutions different from that of Canada goose/US(OH)/87-78/1987 were identified in viruses of the three subgenotypes. Specifically, 8 common substitutions were shared by almost all viruses in the three subgenotypes. In addition, one substitution was shared by isolates of genotypes 1.2 and 1.1.1, and 26 substitutions were shared by viruses of genotypes 1.1.1 and 1.1.2. Furthermore, 2, 24, and 34 characteristic substitutions distinct from isolates of other genotypes in class I were found in genotypes 1.2, 1.1.1, and 1.1.2, respectively (Table 1 and Fig. S2).
TABLE 1.
Unique nucleotide substitutions in subgenotypes
| Description | Substitution and position | No. |
|---|---|---|
| Universal substitutions in the three subgenotypes | A177G, G222A, A315G, A936G, A1051G, C1125T, A1230G, and G1602A | 8 |
| Substitutions shared by genotypes 1.2 and 1.1.1 | C1356T | 1 |
| Substitutions shared by genotypes 1.1.1 and 1.1.2 | C43T, T50C, T65C, A81G, G83A, G84A, C241T, G352A, G501A, C510T, G525A, C657T, C711T, T771C, T828C, C918T, T927C, T941A, C1026T, T1044C, C1080T, T1119C, C1320T, C1441T, C1467T, and C1560A | 26 |
| Characteristic substitutions in genotype 1.2 | C1272T and T1554C | 2 |
| Characteristic substitutions in genotype 1.1.1 | G52A, C56T, A143G, A195G, T204C, T261G, G338A, C405A, C420A, G493A, G526A, T531C, A558G, A612G, T990C, G1029A, C1156A, C1203T, A1334G, C1359T, T1395C, C1432T, G1564A, and G1591T | 24 |
| Characteristic substitutions in genotype 1.1.2 | G54A, C94T, G144A, T193C, C201A, A333T, G357A, G402A, T441C, G465A, A492G, A507T, C561T, A666G, C690T, G699A, A753T, G930A, C942T, T1009C, C1059T, T1092C, T1149C, A1155G, A1206G, C1212T, G1314A, G1362A, G1398A, G1440A, G1465A, T1485C, A1524G, and C1617T | 34 |
Genomic characteristics of representative class I isolates.
To further investigate the genomic molecular characteristics of the NDV isolates showing mutations at the site of the conventional start codon (CSC) (ATG/4556-4558) of the F gene, the complete genomes of FJ28, GX720, FJ120, HeN325, and SH101 were further sequenced and analyzed. Detailed information of the genomic characteristics and proteins of the five isolates is provided in Table 2.
TABLE 2.
Genome characteristics and protein length of class I NDV FJ28, GX720, FJ120, HeN325, and SH101a
| Gene | Length (nt) of: |
Deduced protein size (aa) | ||||
|---|---|---|---|---|---|---|
| Total gene | 5′ UTR | ORF | 3′ UTR | Intergenic sequence | ||
| NP | 1,746 (56–1,801) | 66 | 1,470 | 210 | 2 | 489 |
| P | 1,463 (1,804–3,266) | 83 | 1,200 | 180 | 1 | 399 |
| M | 1,241 (3,268–4,508) | 34 | 1,095 | 112 | 1 | 364 |
| F | 1,792 (4,510–6,301) | 13/34 | 1,695/1,674b | 84 | 31 | 564/557 |
| HN | 2,001 (6,333–8,333) | 91 | 1,851/1,776c | 59/134 | 48 | 616/591 |
| L | 6,703 (8,382–15,084) | 11 | 6,615 | 77 | 2,204 | |
UTR, untranslated region.
The ATG at the site of the conventional start codon of the F gene (4556 to 4558 in the genome) in FJ28, GX720, FJ120, HeN325, and SH101 was absent. Two additional ATG codons were found in the F gene (4523 to 4525 and 4544 to 4546 in the genome) from FJ28, GX720, FJ120, HeN325, and SH101, resulting in two potential ORFs, named ORF-1695 and ORF-1674.
The length of the HN ORF of FJ28, GX720, FJ120, and HeN325 was 1,851 nt, while the length of the HN ORF of SH101 was 1,776 nt.
The full-length genomes of FJ28, GX720, FJ120, HeN325, and SH101 consisted of 15,198 nt with six genes in the order 3′-NP-P-M-F-HN-L-5′, which was similar to that of other class I NDVs. All five isolates had the same length of 3′ leader and 5′ trailer sequences, which consisted of 55 and 114 nt, respectively. Mutation at ATG/4556-4558 resulted in the presence of two potential ORFs, ORF-1695 and ORF-1674, which encode F proteins of 564 and 557 amino acids (aa), respectively. In addition, the HN ORF of FJ28, GX720, FJ120, and HeN325 contained 1,851 nt, encoding an HN protein of 616 aa, while the HN ORF of SH101 consisted of 1,776 nt, encoding an HN protein of 591 aa, which was different from those of all other known NDVs. Further analysis showed that the five potential N-glycosylation sites in the HN protein were conserved in our five isolates, FJ027 (genotype 1.1.2), NDV08-004 (genotype 1.1.1), and NDV08-046 (genotype 1.2). In comparison with FJ28, substitutions, such as F74I and V76A in NDV08-046, I84T in SH101, L102A, A106S, and T108A in NDV08-004, and L102T in NDV08-046, were found in the heptad repeat region (39). Compared with FJ28, substitutions were also identified in the neutralizing epitope region (40–43), such as K197R in NDV08-046, R263Q in NDV08-004 and NDV08-046, D287E in GX720, D347G in SH101, H348Q in NDV08-004 and NDV08-046, R353K in NDV08-004, and K569E in NDV08-046 (Fig. 4). In addition, the amino acid sequences of F and HN proteins showed a higher level of genetic diversity than those of other proteins in the isolates of genotype 1.1.2 (Table 3).
FIG 4.

Predicted amino acid sequence alignment of the HN protein from FJ28, GX720, FJ120, HeN325, SH101, and other representative class I isolates (genotype 1.1.2 isolate, FJ027; genotype 1.1.1 isolate, NDV08-004; genotype 1.2 isolate, NDV08-046). The determinant amino acids of the neutralizing epitopes, potential N-glycosylation sites, and the heptad repeat regions are indicated. The different lengths of the HN protein are marked with asterisks. The length of the HN protein of FJ28, GX720, FJ120, and HeN325 was 616 aa, while the length of the HN protein of SH101 was 591 aa.
TABLE 3.
Nucleotide and amino acid sequence identities of FJ28, GX720, FJ120, HeN325, SH101, and other representative class I NDVsa
| Strain (numbers of references) | Genotype | Genome | Leader | % nucleotide/amino acid identity |
Trailer | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| NP | P | M | F | HN | L | |||||
| FJ28 | 1.1.2 | 100 | 100 | 100/100 | 100/100 | 100/100 | 100/100 | 100/100 | 100/100 | 100 |
| GX720 | 1.1.2 | 97.1 | 100 | 99.1/100 | 99.6/99.5 | 98.5/99.7 | 96.0/97.0 | 95.8/97.2 | 97.0/99.1 | 95.6 |
| FJ120 | 1.1.2 | 99.1 | 100 | 99.1/100 | 99.7/99.8 | 98.5/99.7 | 99.4/99.1 | 98.9/99.0 | 99.2/99.7 | 98.2 |
| HeN325 | 1.1.2 | 98.1 | 98.2 | 98.7/99.6 | 98.7/99.2 | 98.0/99.5 | 97.9/97.5 | 98.0/98.1 | 98.3/99.5 | 96.5 |
| SH101 | 1.1.2 | 97.9 | 100 | 98.4/99.4 | 98.2/97.0 | 98.0/99.5 | 97.3/97.9 | 97.5/97.3 | 98.2/99.4 | 95.6 |
| FJ027 (17) | 1.1.2 | 97.2 | 100 | 98.0/99.8 | 97.7/98.8 | 97.5/99.5 | 97.2/97.0 | 97.2/98.1 | 97.4/99.1 | 94.7 |
| NDV08-004 (3) | 1.1.1 | 92.0 | 94.5 | 93.5/96.9 | 92.2/90.2 | 91.9/97.0 | 92.7/93.8 | 90.9/93.5 | 93.2/97.4 | 86.0 |
| NDV08-046 (3) | 1.2 | 91.6 | 98.2 | 93.3/97.1 | 92.8/92.0 | 91.3/96.7 | 92.2/95.2 | 90.4/92.5 | 92.8/98.1 | 86.8 |
The parenthetical values in the first column are the numbers of references which reported the corresponding NDV strains. The values in the “Genome,” “Leader,” and “Trailer” columns are the Nucleotide identity (percentages).
Class I isolates with specific mutations at the CSC site of the F gene demonstrate increased virulence and replication capacity.
Isolates FJ28, GX720, FJ120, SH101, and HeN325 were selected and used for pathogenicity tests on the basis of the mutation at the CSC site of the F gene (Fig. 5A). The previously reported genotype 1.1.2 isolate FJ027 with ATG/4556-4558 was used as a control (17). The results of pathogenicity tests showed that the mean death times (MDT) of FJ28, GX720, FJ120, SH101, HeN325, and FJ027 were 108 h, 112 h, 134 h, >168 h, >168 h, and >168 h, respectively. The intracerebral pathogenicity indexes (ICPI) of FJ28, GX720, FJ120, SH101, HeN325, and FJ027 were 0.86, 0.77, 0.32, 0.24, 0.25, and 0.23, respectively. These results indicated that the virulence index of FJ120 was slightly higher than that of FJ027, while the virulence indexes of FJ28 and GX720, especially FJ28, were significantly higher than that of FJ027.
FIG 5.
The growth kinetics of class I isolates in ovo. (A) Sequence characteristics of the start codons of the F gene at genomic positions 4523 to 4525, 4544 to 4546, and 4556 to 4558. The 4523–4558 regions in FJ28, GX720, FJ120, SH101, HeN325, and FJ027, a representative genotype 1.1.2 class I isolate, were aligned. (B) FJ28, GX720, FJ120, SH101, HeN325, and FJ027 were inoculated into the allantoic cavities of 9-day-old embryonated SPF eggs in 100 μL containing 100 median embryo infectious doses (EID50). The allantoic fluids of five eggs receiving each virus were harvested at 24, 48, 72, 96, and 120 hpi. The viral titers were determined in SPF eggs and are expressed as EID50. Data are means and SD and were analyzed using one-way analysis of variances (*, P < 0.05; **, P < 0.01; ***, P < 0.001).
The growth kinetics of FJ28, GX720, FJ120, SH101, HeN325, and FJ027 in specific-pathogen-free (SPF) embryonated chicken eggs were determined to compare the replication capacities of these viruses in ovo. As shown in Fig. 5B, the viral titers of FJ28 and GX720 were significantly higher than those of FJ120, SH101, HeN325, and FJ027 at each time point. FJ120 had a higher viral titer than SH101, HeN325, and FJ027, while SH101, HeN325, and FJ027 showed comparable viral titers at each time point. We also found that replication of FJ28 and GX720 resulted in serious hemorrhage of the chicken embryo. In contrast, no obvious lesions were observed in chicken embryos inoculated with FJ120, SH101, HeN325, and FJ027 (data not shown). These results indicate that the replication capacity of isolates FJ28, GX720, and FJ120 was higher than that of the isolates with ACG/4556-4558 (SH101 and HeN325) and ATG/4556-4558 (FJ027), among which the isolates with ATA/4556-4558 (FJ28 and GX720) demonstrated the highest replication level. The high replication level of these viruses in ovo could contribute to the increased virulence, as previously reported (25).
Replacement of the F gene of LaSota with that of FJ28 leads to increased virulence.
In order to investigate the contribution of specific mutations in the F gene to the increased virulence of class I FJ28, a class II genotype II lentogenic strain, LaSota, was used as a model in our reverse genetic system (44, 45). First, a plasmid (pNDFL) containing the full-length cDNA of LaSota was used (27, 44), and the F gene in the plasmid was replaced by that of FJ28 (Fig. 6A). Then, the recombinant virus (rLa-FJ28F) was rescued as we previously described (44, 45). The pathogenicity assay showed that the MDT of LaSota and rLa-FJ28F were 100 h and 115 h, respectively, and the ICPI of LaSota and rLa-FJ28F were 0.19 and 0.73, respectively. In addition, the HN gene of rLa-FJ28F was replaced by that of FJ28 using a similar method, and the recombinant virus rLa-FJ28FHN was rescued (Fig. 6A). The MDT and ICPI of rLa-FJ28FHN were 115 h and 0.74, respectively. These data indicate that the F gene rather than the HN gene of FJ28 was the key determinant of the increased virulence of the recombinant virus.
FIG 6.

Construction of recombinant plasmids. (A) Schematic diagram of the construction of pNDV-FJ28-F, pNDV-FJ28-FHN, and pNDV-FJ28-FHN-ATG, -CTA, and -ACG. (B) Schematic diagram of the construction of PFJ28FL (a), PFJ28FL-ATG and -CTA (b), and PFJ28FL-1695, -1674, and -1662 (c). (C) Schematic diagram of the construction of PNDV-ATA and -CTA.
To further evaluate the contribution of the mutation at ATG/4556-4558 to the increased virulence of the virus, three recombinant viruses, rLa-FJ28FHN-ATG (ATA to ATG), rLa-FJ28FHN-CTA (ATA to CTA), and rLa-FJ28FHN-ACG (ATA to ACG), were rescued (Fig. 6A). The pathogenicity assay showed that the MDT of rLa-FJ28FHN-ATG, rLa-FJ28FHN-CTA, and rLa-FJ28FHN-ACG were >168 h, 130 h, and >168 h and their ICPI were 0.24, 0.29, and 0.28, respectively. These findings indicate that the specific ATA/4556-4558 in the F gene of the class I isolate FJ28 is likely a key determinant of the increased virulence of the recombinant virus.
The specific codon ATA/4556-4558 in FJ28 is the determinant of the increased virulence and replication capacity in ovo.
To validate the effects of ATA/4556-4558 on the virulence and replication of FJ28, a plasmid (PFJ28FL) containing the full-length cDNA of FJ28 was constructed on the basis of transcription vector pOLTV5 (Fig. 6B, panel a), and the virus rFJ28 was rescued. Then, the ATA-to-ATG mutation was introduced into the plasmid PFJ28FL (Fig. 6B, panel b). In addition, in light of the slight increases in virulence and replication capacity of FJ120 with CTA/4556-4558 compared to those of viruses with ACG/4556-4558 and with ATG/4556-4558, the ATA-to-CTA mutation was also introduced into the plasmid PFJ28FL (Fig. 6B, panel b), and two recombinant viruses, rFJ28-ATG and rFJ28-CTA, respectively, were rescued. The pathogenicity assay showed that the MDT of rFJ28, rFJ28-ATG, and rFJ28-CTA were 113 h, 134 h, and 121 h and their ICPI were 0.88, 0.28, and 0.38, respectively.
The growth kinetics of rFJ28, rFJ28-ATG, and rFJ28-CTA in SPF embryonated chicken eggs were also determined to compare the replication capacities of these viruses in ovo. As shown in Fig. 7A, panel a, the viral titer of rFJ28 was significantly higher than those of rFJ28-ATG and rFJ28-CTA at each time point. In addition, the viral titer of rFJ28-CTA was higher than that of rFJ28-ATG at each time point. Moreover, the replication of rFJ28 resulted in serious hemorrhage in the chicken embryos, while no obvious lesions were observed in the chicken embryos which were inoculated with rFJ28-ATG and rFJ28-CTA (data not shown). These findings indicate that although the recombinant virus rFJ28 with ATA/4556-4558 and rFJ28-CTA with CTA/4556-4558 presented increased virulence and replication capacity in ovo, ATA/4556-4558 specifically contributes significantly to the increase of virulence and replication capacity. Therefore, the replication capacity of the rFJ28 and rFJ28-ATG in vivo was further determined in SPF chickens.
FIG 7.

Growth kinetics of rescued class I (A) and class II (B) viruses in ovo and in vivo. (A) (a) Growth kinetics of rFJ28, rFJ28-CTA, and rFJ28-ATG in ovo. Each of the viruses was inoculated into the allantoic cavities of 9-day-old embryonated SPF eggs in 100 μL containing 100 EID50. The allantoic fluids of five eggs receiving each virus were harvested at 24, 48, 72, 96, and 120 hpi. The viral titers were determined in SPF eggs and are expressed as EID50. Data are means and SD and were analyzed using one-way analysis of variance. (b) The growth kinetics of rFJ28 and rFJ28-ATG in vivo. Five-day-old SPF chicks were inoculated with rFJ28 and rFJ28-ATG via the oculonasal route, with a dose of 106 EID50/100 μL per chick. Three birds from each group were killed humanely at 12, 24, 36, 48, 72, 96, and 120 hpi, and tissue samples of the Harderian gland, trachea, lung, spleen, cecal tonsil, and intestine were harvested. Viral load was analyzed using real-time RT-PCR. Data are means and SD and were analyzed using Student’s t test. (B) The growth kinetics of LaSota, rLaSota-ATA, and rLaSota-CTA in ovo (a) and the growth kinetics of LaSota and rLaSota-ATA in vivo (b) were determined as described for panel A. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
The specific codon ATA/4556-4558 in FJ28 is the determinant of the increased replication capacity in chickens.
All chickens infected with rFJ28 and rFJ28-ATG exhibited no apparent clinical signs and remained alive until the end of the animal experiments, similar to the birds in the control group. In addition, NDV RNA was detected in the tissue samples of the Harderian gland, trachea, lung, spleen, cecal tonsil, and intestine from the chickens infected with rFJ28 and rFJ28-ATG at 12, 24, 36, 48, 72, 96, and 120 h postinoculation (hpi) using real-time RT-PCR. As shown in Fig. 7A, panel b, viral RNA could be detected in the Harderian gland and trachea from rFJ28- and rFJ28-ATG-infected chickens at all time points from 12 hpi, and the viral loads in the two organs from rFJ28-infected chickens were significantly higher than those in rFJ28-ATG-infected chickens at each time point. Viral RNA could be detected in the lungs from rFJ28- and rFJ28-ATG-infected chickens from 48 and 72 hpi, respectively. The viral loads in lungs from rFJ28-infected chickens were significantly higher than those of rFJ28-ATG-infected chickens at each time point from 72 hpi. In addition, viral RNA could be detected in the spleens, cecal tonsils, and intestine from rFJ28- and rFJ28-ATG-infected chickens from 72 hpi, and the viral loads in these organs from rFJ28-infected chickens were significantly higher than those of rFJ28-ATG-infected chickens at each time point. In addition, no viral RNA was detected in all tissue samples of the birds in the control group (data not shown). These results indicated that ATA/4556-4558 in the F gene of FJ28 is the critical determinant of the increased replication capacity of FJ28 both in ovo and in vivo.
Mutations at the CSC site of the F gene in genotype II LaSota of class II has no effects on the virulence and replication capacity.
Based on the genome annotation of LaSota, only one ORF was found in the F gene, in which the start codon and terminal codon were located at genomic positions 4544 to 4546 and 6203 to 6205, respectively (5). In order to imitate the mutations in the F gene of class I isolates and evaluate the effects on virulence and replication capacity, the CSC of the F gene in pNDFL (genomic positions 4544 to 4546 in LaSota) was mutated to ATA and CTA. Meanwhile, the nucleotides located at 4511 to 4513 (TCT) and 4532 to 4534 (TCC) in the genome were mutated to ATG (Fig. 6C). These mutations resulted in two potential ORFs, ORF-1695 and ORF-1674, in the F gene. Then, two recombinant viruses, rLaSota-ATA and rLaSota-CTA, were rescued. The pathogenicity assay showed that the MDT of LaSota, rLaSota-ATA, and rLaSota-CTA were 100 h, 107 h, and 110 h, and their ICPI were 0.19, 0.24, and 0.25, respectively. The growth kinetics of LaSota, rLaSota-ATA, and rLaSota-CTA in SPF embryonated chicken eggs indicated that there were no significant differences among LaSota, rLaSota-ATA, and rLaSota-CTA (Fig. 7B, panel a). No obvious lesions were observed in the chicken embryos inoculated with LaSota, rLaSota-ATA, and rLaSota-CTA (data not shown). These data suggest that both ATA and CTA mutations had no effects on the virulence and replication capacity in ovo of class II genotype II LaSota.
Moreover, the replication capacities of LaSota and recombinant rLaSota-ATA in vivo were further determined in SPF chickens. As shown in Fig. 7B, panel b, viral RNA could be detected in the Harderian glands, tracheas, lungs, spleens, cecal tonsils, and intestines from LaSota- and rLaSota-ATA-infected chickens from 12, 12, 48, 72, 72, and 72 hpi, respectively. The viral loads in all tissue samples from LaSota-infected chickens were comparable to those of rLaSota-ATA-infected chickens at each corresponding time point. The aforementioned results demonstrated that the corresponding codon mutation found in the F gene of class I isolates had no effects on the virulence and replication capacity in ovo and in vivo of class II genotype II LaSota.
CSC mutations of FJ28 affect the expression of F protein on the surface of infected cells.
To evaluate the effect of CSC mutations on the expression of F protein, the expression level of F protein in virus-infected cells was evaluated by flow cytometry. In consideration of the facts that CSC mutations led to the amino acid substitution in the signal peptide and that the amino acid substitution may affect the transport of F protein to the plasma membrane, the expression levels of total F protein and F protein on the cell surface were investigated. Regarding the percentage of F-positive cells and the expression level of total F protein, as indicated by the mean fluorescence intensities, the results showed that the DF-1 cells infected with rFJ28 were comparable to those infected with rFJ28-CTA- and rFJ28-ATG (Fig. 8A and B) when the cells were infected with rFJ28, rFJ28-CTA, and rFJ28-ATG at the same multiplicity of infection (MOI). In contrast, the expression level of the F protein on the surfaces of rFJ28 infected DF-1 cells was significantly higher than that in rFJ28-CTA- and rFJ28-ATG-infected DF-1 cells. Moreover, the expression level of the F protein on the surface of rFJ28-CTA-infected DF-1 cells was higher than that in rFJ28-ATG-infected cells (Fig. 8B). These data indicated that the CSC mutations affected the expression level of F protein on the surfaces of infected cells, rather than the expression level of total F protein. The different expression levels of F protein on the surface of infected cells were consistent with the replication capacities and virulence of corresponding viruses (Fig. 7A, panels a and b).
FIG 8.

Expression of F protein in rFJ28-, rFJ28-CTA-, and rFJ28-ATG-infected DF-1 cells. DF-1 cells were infected with each virus at an MOI of 1. The percentage of F-positive cells (A) and the expression levels of total F protein and F protein on the surface of infected cells (B) were assessed by flow cytometry at 24 hpi with an anti-NDV F protein antibody and an FITC-conjugated secondary antibody. Immunofluorescence was quantified by fluorescence-activated cell sorting analysis using a Cytomics FC 500 flow cytometer. Data are means and SD and were analyzed using one-way analysis of variance (**, P < 0.01; ***, P < 0.001).
ATG/4523-4525 was the authentic start codon in F gene of the class I NDV.
To evaluate whether ATG/4523-4525, ATG/4544-4546, or ATG/4556-4558 was alternatively used as the start codon for F protein expression in class I NDV, recombinant viruses rFJ28-1695, rFJ28-1674, and rFJ28-1662, which contain only ORF-1695, ORF-1674, and ORF-1662, respectively, were rescued, and the expression level of total F protein, expression level of F protein on the surfaces of infected cells, and growth kinetics of these recombinant viruses were compared with those of parental rFJ28. The results showed that there were no significant differences in the percentages of F-positive cells among cells infected with rFJ28, rFJ28-1695, rFJ28-1674, and rFJ28-1662 at the same MOI (Fig. 9A, panel a). Notably, the expression levels of total F protein and F protein on the surfaces of infected cells were comparable in DF-1 cells infected with rFJ28 and those infected with rFJ28-1695, and they were lower in DF-1 cells infected with rFJ28-1674 and rFJ28-1662 (Fig. 9A, panel b). Moreover, the growth kinetics of rFJ28, rFJ28-1695, rFJ28-1674, and rFJ28-1662 in SPF embryonated chicken eggs were determined to compare the replication capacities of these viruses. Consistent with the expression level of F protein on the surfaces of infected cells, the viral titers of rFJ28 and rFJ28-1695 were comparable and higher than those of rFJ28-1674 and rFJ28-1662 at each time point. In addition, rFJ28-1662 had a higher viral titer than rFJ28-1674 at each time point (Fig. 9B). These results indicated that the ATG/4523-4525 and corresponding ORF-1695 significantly contribute to the efficient expression of F protein and virus replication capacity.
FIG 9.

Characteristics of recombinant viruses with ORF-1695, ORF-1674, and ORF-1662. (A) Percentages of F-positive cells (a) and expression levels of total F protein and F protein on the surfaces of rFJ28-, rFJ28-1695-, rFJ28-1674-, and rFJ28-1662-infected DF-1 cells (b). DF-1 cells were infected with each virus at an MOI of 1. At 24 hpi, the expression of F protein in virus-infected cells was assessed by flow cytometry as described above. (B) The growth kinetics of rFJ28, rFJ28-1695, rFJ28-1674, and rFJ28-1662 in ovo. Each virus was inoculated into the allantoic cavities of 9-day-old embryonated SPF eggs with 100 μL of 100 EID50. The allantoic fluids of five eggs receiving each virus were harvested at 24, 48, 72, 96, and 120 hpi. The viral titers were determined as described above. (C) Characteristics of the nucleotide sequences around the three possible start codons in the F gene of class I NDVs located at genomic positions 4523 to 4525, 4544 to 4546, and 4556 to 4558. The genomic sequences of 5 class I NDV isolates determined in this study (FJ28, GX720, FJ120, SH101, and HeN325) and 70 class I NDV strains with complete genomic sequences deposited in GenBank were compared (Table S4). The A of the ATG was numbered +1, the preceding nucleotides were successively numbered −1, −2, and −3, and the following nucleotides were successively numbered +2, +3, and +4. Nt, nucleotide; Num, number; Per, percent. Data are means and SD and were analyzed using one-way analysis of variance (*, P < 0.05; **, P < 0.01; ***, P < 0.001).
To further confirm these results, the nucleotide sequences around the three possible start codons of the F gene in class I NDVs were analyzed, because it is believed that sequences in this region are critical for the translation initiation (46, 47). As shown in Fig. 9C, the G purine at the −3 and +4 positions in F gene around ATG/4523-4525 were universally conserved in all sequences. For sequences around ATG/4544-4546, pyrimidines (C, 96%, and T, 4%) were found at the −3 position and purines (G, 97.3%, and A, 2.7%) were found at the +4 position. Among the sequences around the ATG/4556-4558, a purine (A, 98.3%) and a pyrimidine (T, 1.3%) were found at the −3 position and a purine (G, 98.7%) and a pyrimidine (C, 1.3%) were found at the +4 position. Based on the results in this study, as well as previous findings (46–48), we concluded that the ATG/4523-4525 in F gene was preferential adopted for translation initiation. This was in agreement with the results regarding the expression of F protein and replication capacities of recombinant viruses. Conclusively, though other ATG codons exist, the ATG/4523-4525 in F gene of class I NDV is the authentic start codon that is utilized for protein expression.
DISCUSSION
Surveillance of class I NDVs derived from LBMs in some provinces in China, such as Guangdong (49), Jiangsu (15), and Jilin (50), has been reported. To our knowledge, however, comprehensive investigations at a nationwide level have not been reported. In this study, the identification and characterization of class I NDVs at nationwide LBMs in China between 2017 and 2019 was performed. Our results demonstrate that class I NDVs are widespread at LBMs in China. A preference for a certain geographic distribution has not been found, as the isolates were obtained from birds or the environment at LBMs in all 19 surveyed provinces/municipalities. Meanwhile, 28 isolates belonging to class II were also obtained from samples collected from chickens at these LBMs. Of these 28 isolates, 26 were identified as genotype II LaSota-like strains and 2 were identified as genotype I V4-like strains. These data imply that class I rather than class II NDVs are predominant at LBMs in China.
It is believed that waterfowl are a natural reservoir of avirulent NDVs (8, 10, 15). In China, the first class I NDV strain was isolated from waterfowl (duck) at LBMs in 2002 (15). Thereafter, numerous class I NDVs were isolated from ducks, geese, and chickens, including an increasing number of class I NDVs isolated from chickens (19, 20, 50, 51). In this study, class I NDVs were identified from chickens (152, 65.52%), ducks (39, 16.81%), the environment (36, 15.51%), pigeons (4, 1.72%), and geese (1, 0.43%). Together with previous reports (19, 20, 50, 51), the data from this study suggest that class I NDVs are widely distributed in multiple bird species and are potentially being transmitted and circulating among different bird species at LBMs in China.
The pigeon is another natural host of NDVs, and genotype VI NDVs are considered pigeon-adapted viruses derived from the older virulent NDVs, though other genotypes (I, II, and VII) in class II have also been isolated from pigeons (7, 52–54). In 2016, a class I NDV was first reported to be isolated from pigeons in China and was identified as an avirulent strain (18). In this study, 4 NDVs classified as class I were isolated from pigeons at LBMs in different provinces/municipalities with the avirulent motif ERQERL at the cleavage site of the F protein. The ACG mutation at genomic positions 4556 to 4558 was found in isolate SH101 from pigeons. Interestingly, other class I NDV strains, including those isolated from chickens, ducks, and the environment in this study and those of the sequences that were deposited in GenBank (Table S2), also exhibited this mutation in the same genomic positions. Since no obvious host preference was observed for isolates with this mutation, this mutation might be a progressive adaptation of class I NDVs in the new hosts during the transmission and evolution of this virus (54); this needs to be further investigated. Moreover, a recent report demonstrated that the role of pigeons during the dissemination and potential evolution of class I NDVs needs to be taken into account (18).
Available sequences of class I NDVs are currently very limited, and the majority are from the United States and China. So far, three subgenotypes, designated 1.1.1, 1.1.2, and 1.2, are defined based on the available F gene sequences of class I NDVs (3). In China, the class I strains isolated in 2002 and some of the strains isolated from 2006 to 2011 formed a specific branch in genotype 1.2 (genotype 1c) (3, 4). Genotype 1.2 also contains strains isolated from Finland, Japan, Germany, Russia, Kazakhstan, and the United States. Comparatively, genotype 1.2 strains in China showed a close relationship with the isolates from Finland in 1997 and Germany in 1999, in contrast to the strains isolated from 1998 to 2014 from waterfowl and shorebirds in the United States, which were classified in another specific branch in genotype 1.2 (genotype 1d) (3, 4).
Since all these class I NDVs could be rooted to the earliest recorded class I NDV, Canada goose/US(OH)/87-78/1987, which was isolated from waterfowl (Canada goose) in 1987 in the United States (3, 8), we speculate that strain goose/US(OH)/87-78/1987 was likely the ancestor of the class I NDVs in the United States. This strain further evolved into different strains classified in the specific branch in genotype 1.2, which persistently circulated in waterfowl and shorebirds. Later, the goose/US(OH)/87-78/1987-like virus may have been introduced into European countries and further evolved into another specific branch in genotype 1.2. Subsequently, this genotype was introduced into China and other countries in Europe. It is interesting to find that although genotype 1.2 first emerged in China in 2002, this genotype was not widely spread in China over time. In contrast, genotypes 1.1.1 and 1.1.2 of class I NDVs were successively identified in China, and genotype 1.1.2 has become the predominant genotype since the first identification in 2009 from ducks and chickens.
Overall, the isolation of class I NDVs was primarily reported from wild birds, waterfowl, and LBMs but not from commercial poultry farms (8–10, 55). Epidemiological analysis indicated that wild birds, which serve as the natural reservoir of class I NDVs, could be the source of class I NDVs in waterfowl and domestic poultry (33, 56, 57). Although the presence of genotype 1.1.1 and 1.1.2 class I NDVs in wild birds was reported in China in 2013 and 2015 (3, 14, 58), there are still very limited data related to the epidemiology of class I NDVs in wild birds in China. In this study, the nucleotide sequences of the F gene coding region were analyzed between Canada goose/US(OH)/87-78/1987 and different genotypes. Although common substitutions were found to be shared by the three subgenotypes which were different from those of Canada goose/US(OH)/87-78/1987, only one common substitution was shared between genotypes 1.2 and 1.1.1, while no common substitutions were observed between genotypes 1.2 and 1.1.2 (Table 1). In contrast, some unique substitutions were generally found between genotypes 1.1.1 and 1.1.2. Based on these findings and previous reports by Chen et al. (49), we hypothesize that genotype 1.2 class I NDVs evolved into two parallel branches, genotypes 1.1.1 and 1.1.2, after they were introduced into wild bird populations in China. Then, the wild birds further disseminated the virus to wild waterfowl and subsequently to domestic poultry, in which genotype 1.1.2 was predominant. Whether it was easier for genotype 1.1.2 to adapt and replicate in birds than genotype 1.1.1 requires further elucidation. These results might help to explain the dominant prevalence of genotype 1.1.2, rather than genotype 1.1.1, in birds in China.
It is generally assumed that the NDV F gene with ATG/4556-4558 contains a single ORF, ORF-1662, encoding an envelope F glycoprotein of 553 amino acids, in which the N-terminal signal peptide is located at aa 1 to 31 (59). However, in addition to this classical ORF, two additional ATG codons, ATG/4523-4525 and ATG/4544-4546, were also found in the F gene from most class I NDVs, resulting in another two potential ORFs, ORF-1695 and ORF-1674. However, whether these ATG codons were alternatively used for protein expression remains to be demonstrated.
In this study, ATA, CTA, or ACG mutations were found at genomic positions 4556 to 4558 in 20 isolates from the 232 class I NDV isolates; ATG/4556-4558 in the F gene was found at this position of the remaining isolates. These mutations resulted in the absence of the classical ORF-1662 but the presence of the potential ORF-1695 and ORF-1674, with an extended N-terminal signal peptide. Although some sequences of F gene with mutations at ATG/4556-4558 in genotype 1.1.2 of class I NDVs have been previously deposited in GenBank (Table S2), the potential effects of the mutations at ATG/4556-4558 on the biological characteristics of these NDVs are unknown.
In addition to the roles in sorting and membrane integration of secretory and membrane proteins (60), the involvement of a viral signal peptide in the replication and virulence of various viruses, such as Lassa virus and foamy virus, has been recognized (61–63). For NDV, it was demonstrated that the alteration of specific amino acids in the signal peptide of the F protein and the HN protein leads to enhanced virulence (31). In this study, we showed that although a few class I NDVs showed distinct mutations, only the isolates with ATA/4556-4558 (FJ28 and GX720) showed significantly increased virulence and replication capacity, implying that the specific ATG to ATA mutation might be the key determinant. Subsequently, we further demonstrated that the ATG/4523-4525 in the F gene of class I NDV is the authentic start codon that is utilized for protein expression, although other ATGs were also found, resulting in an F protein with an extended N-terminal signal peptide (aa 1 to 42) that is longer than that of the classical NDV F protein. Since the extended signal peptide is beneficial for the efficient processing and translocation of precursor proteins (64, 65), we inferred that the increased length of F signal peptide should also contribute to the efficient expression of F protein on the surface of infected cells. It has been suggested that the high hydrophobicity of a signal peptide is critical for the rapid processing and translocation of precursor proteins (64, 66); thus, the descending hydrophobicity indexes of isoleucine (4.5), leucine (3.8), and methionine (1.9), encoded by ATA, CTA, and ATG at 4556 to 4558 in rFJ28, rFJ28-CTA, and rFJ28-ATG, respectively, could be responsible for the expression level of F protein on the surface of infected cells. This was in accordance with the replication capacities and virulence of these recombinant viruses. Collectively, our findings indicated that the alteration of specific amino acids in the signal peptide caused by the ATA/4556-4558 mutation was responsible for the increased replication capacity of class I NDVs and further contributes to the enhanced virulence of the virus (25).
Disease outbreaks caused by virulent class I isolates and variants of class II genotype I viruses have been reported in Ireland and Australia (11, 33), respectively, indicating the potential of avirulent NDVs to evolve into the virulent phenotype under natural conditions. Recently, the increased virulence of avirulent class I NDVs after continuous passage in chickens has been reported, and the transitional types of viruses from avirulent to virulent have been identified (34, 35). Here, we demonstrate that the virulence of class I isolates with ACG/4556-4558 is comparable to that of the classical genotype 1.1.2 isolate with ATG/4556-4558, while the virulence of isolates with CTA/4556-4558 and ATA/4556-4558 was increased, with isolates harboring ATA/4556-4558 exhibiting significantly increased virulence. Although the virulence indexes (MDT and ICPI) of isolates with ATA/4556-4558 indicated increased virulence, chickens incubated with the representative isolate demonstrated no obvious clinical signs. Therefore, we speculate that the gradually increased virulence of isolates with ACG/4556-4558, CTA/4556-4558, and ATA/4556-4558 may represent the transitional types during the evolution of class I NDVs from avirulent to virulent, similar to that found in viruses of class I under experimental conditions (34, 35). Whether these isolates could serve as the progenitor virus from which the virulent virus originated as previously reported needs to be investigated (33).
For commercial poultry in China, especially chickens, virulent class II NDVs have been infrequently isolated in recent years, while class II genotype II vaccine-like strains are predominantly isolated, possibly due to the intensive vaccination policy employed with class II genotype II vaccines (67). As the increased virulence of avirulent NDVs under natural and experimental conditions has been confirmed, the mass application and persistent circulation of vaccine viruses in poultry pose a potential risk for the emergence of virulent NDVs (11, 34, 35). Thus, the effects of the corresponding mutations found in the F gene in class I NDVs on the virulence and replication capacity of class II genotype II vaccine viruses (LaSota strain) were evaluated. Interestingly, the ATA mutation at the CSC site in the F gene had no effects on the virulence and replication capacity of recombinant virus rLaSota-ATA, suggesting that the alteration of virulence and replication capacity caused by the ATA/4556-4558 mutation could be a characteristic of class I NDVs.
MATERIALS AND METHODS
Cells, eggs, and animals.
BSR-T7/5 and DF-1 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 5% and 10% heat-inactivated fetal bovine serum (FBS), respectively. SPF embryonated chicken eggs and chicks (National Poultry Laboratory Animal Resource Center, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences) were used in this study. All animal protocols were approved by the Animal Welfare Committee of Heilongjiang Province, China (no. HVRI-IACUC-2019-220). All experiments were conducted at appropriate biosafety levels.
Virus identification.
Allantoic fluids which showed hemagglutination (HA) activity but did not contain avian influenza virus were obtained from the Animal Influenza Laboratory of the Ministry of Agriculture, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences. These allantoic fluids were collected from the SPF embryonated eggs inoculated with swab samples of clinically healthy birds and environmental samples (feces-contaminated water and soil) at LBMs in different provinces in China (Table S1). All the allantoic fluids were passaged once by inoculation into 10-day-old embryonated chicken eggs. After incubation for 48 h at 37°C, allantoic fluid was collected for HA and hemagglutination inhibition (HI) assays by using a panel of reference antisera against the 16 HA subtypes of avian influenza virus and antisera against NDV as described previously (68). Ultimately, a total of 260 isolates with HA activity that could be inhibited by antisera against NDV, rather than antisera against avian influenza virus, were obtained.
The 260 isolates were further identified as class I and II NDVs using real-time RT-PCR assays as previously described (9, 69). In total, 232 isolates were identified as class I NDVs and the other 28 isolates were identified as class II NDVs. For some of the viruses used in the subsequent assays, virus stocks were prepared by inoculating 9-day-old SPF embryonated chicken eggs once, and the titers were determined by inoculation at 10-fold dilutions into groups of five 10-day-old embryonated chicken eggs and expressed as median embryo infectious dose (EID50) as previously described (70).
RNA extraction, RT-PCR, and sequencing.
Viral RNAs were extracted from infectious allantoic fluid using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. The genomic fragments at positions 4304 to 6578 containing the F gene of class I NDVs were amplified by using primers FF (5′-AGGGCTGTGGCTGTGACTGCAGACCAC-3′) and FR (5′-GTGCTAGCATTCATGCTGAATGCGAGGG-3′) via reverse transcription-PCR (RT-PCR). In addition, the complete genomes of DK/CH/LFJ/28/2017 (FJ28), EN/CH/LGX/720/2019 (GX720), DK/CH/LFJ/120/2017 (FJ120), CK/CH/LHeN/325/2017 (HeN325), and PI/CH/LSH/101/2018 (SH101) were amplified with a one-step RT-PCR kit (TaKaRa, Dalian, China) using our previously published primers (17). The 3′- and 5′-terminal regions of the viral genome were amplified by rapid amplification of cDNA ends (RACE) using a 3′/5′ RACE kit (TaKaRa) as previously described (71–73). All PCR products were purified and cloned into the pMD18-T vector (TaKaRa), and each fragment of the viral genome was sequenced at least three times to determine a consensus sequence (17, 74). Sanger sequencing was conducted by the BGI (Beijing, China).
Sequence and phylogenetic analysis.
The nucleotide sequence assembly, alignment, coding sequence search, and prediction of amino acid sequences were conducted with DNASTAR’s Lasergene sequence analysis software (75) and Geneious Basic software (76). The complete F gene sequences of all 232 class I NDV strains were combined with the class I F gene data set established by Dimitrov et al. in February 2019 for phylogenetic analysis (https://github.com/NDVconsortium/NDV_Sequence_Datasets/blob/master/Feb_21_2019/NDV_class_I_284_Feb_21_2019.fas) (3). On the basis of the complete F gene ORF, a phylogenetic tree was constructed with MEGA X software using maximum likelihood with 1,000 bootstraps (77).
Construction of recombinant plasmids.
The construction of plasmids containing the backbone of the LaSota genome and the F and HN genes of FJ28 was based on the plasmid (pNDFL) containing the full-length cDNA of the LaSota genome (27, 44). Briefly, the fragment containing positions 3210 to 4497 was amplified from pNDFL with primers La-FJ28-F-1 and La-FJ28-F-2, and the fragment containing positions 6290 to 8109 was amplified from pNDFL with primers La-FJ28-F-5 and La-FJ28-F-6. The F gene of FJ28 at genomic positions 4510 to 6301 was amplified from isolate FJ28 with primers La-FJ28-F-3 and La-FJ28-F-4. Then, the overlap PCR was conducted with primers La-FJ28-F-1 and La-FJ28-F-6 using the three fragments to obtain a chimeric fragment. The PCR product was cloned between the PmeI and SpeI sites of pNDFL via the In-Fusion cloning kit (TaKaRa, Dalian, China). The resultant plasmid, which contained the backbone of LaSota but the F gene of FJ28, was designated pNDV-FJ28-F (Fig. 6A). Then, a similar strategy was used to construct a plasmid containing the backbone of LaSota but the F and HN genes of FJ28. The resultant plasmid was designated pNDV-FJ28-FHN (Fig. 6A). To introduce mutations at the CSC site of the F gene, site-directed mutagenesis was performed on pNDV-FJ28-FHN to generate a cluster of fragments with mutations using overlap PCR with specific primers. The nucleotides at the CSC site in the F gene were mutated to ATG, CTA, and ACG. All PCR products with the specific mutation were cloned between the PmeI and HpaI sites of pNDV-FJ28-FHN using the In-Fusion cloning kit. The resulting plasmids were designated pNDV-FJ28-FHN-ATG, -CTA, and -ACG, respectively (Fig. 6A).
For construction of the plasmid containing the full-length FJ28 cDNA, the transcription vector pOLTV5 was used (27, 44). Briefly, the pOLTV5 vector was amplified by PCR with primers containing 15 nt of the FJ28 genomic 3′- and 5′-terminal sequences. The 1–1462 and 13126–15198 regions of the FJ28 genome were amplified and fused to generate a chimera containing a PmeI restriction site (GTTTAAAC). Then, the constructed chimera was cloned into the pOLTV5 vector to generate plasmid PFJ28-1 using the In-Fusion cloning kit. Then, four fragments containing genomic positions 1463 to 4063, 4064 to 7382, 7383 to 10703, and 10704 to 13125 of FJ28 were amplified and successively cloned into the plasmid PFJ28-1 through the PmeI restriction site using the In-Fusion cloning kit to generate a plasmid containing the full-length cDNA of FJ28, designated PFJ28FL (Fig. 6B, panel a). Subsequently, nucleotides ATA in PFJ28FL, which correspond to genomic positions 4556 to 4558 in FJ28, were mutated to ATG and CTA using the above-described strategy. The resulting mutated plasmids were designated PFJ28FL-ATG and -CTA (Fig. 6B, panel b). Moreover, the ATG located at the genomic positions 4523 to 4525 and 4544 to 4546 of FJ28 in PFJ28FL was mutated to ACG and GTG, the second most frequent codon in our 232 isolates at the corresponding sites, respectively. The resulted mutated plasmids were designated PFJ28FL-1674 and PFJ28FL-1695, respectively (Fig. 6B, panel c). Then, the ATG and ATA located at genomic positions 4544 to 4546 and 4556 to 4558 of FJ28 were mutated to GTG and ATG in plasmid PFJ28FL-1674, respectively. The resulting mutated plasmid was designated PFJ28FL-1662 (Fig. 6B, panel c).
To evaluate the potential effects of the mutations found at the CSC site in the F gene of class I FJ28 on the biological characteristics of class II NDVs, genotype II LaSota was used as a model. The F gene in plasmid pNDFL was modified to imitate the ORF organization of the F gene in FJ28. Specifically, the nucleotides ATG in pNDFL, which correspond to genomic positions 4544 to 4546, the CSC site in the F gene, were mutated to ATA and CTA. In addition, nucleotides TCT and TCC at genomic positions 4511 to 4513 and 4532 to 4534 in LaSota were mutated to ATG, resulting in two potential ORFs, ORF-1695 and ORF-1674, using the above-described strategy. The resulting mutated plasmids were designated pNDV-ATA and -CTA (Fig. 6C). All primers used for plasmid construction are presented in Table S3.
Rescue and characterization of mutant viruses.
Three helper plasmids, pCI-NP-K, pCI-P-K, and pCI-L-K, were used for virus rescue in this study (44, 45). Transfection and recovery of viruses were carried out as previously described (44, 45). To rescue the viruses, the BSR T7/5 cells cultured in 6-well plates were cotransfected with plasmids containing the full-length cDNA clone together with pCI-NP-K, pCI-P-K, and pCI-L-K using Lipofectamine 2000 (Invitrogen). At 6 h posttransfection, the plasmid-lipid complexes were removed, and the cells were cultured in DMEM supplemented with 5% FBS and 1 μg/mL tosyl phenylalanyl chloromethyl ketone (TPCK)-treated trypsin (Sigma, Shanghai, China) for 3 days. Then, the culture supernatant and cells were harvested and inoculated into the allantoic cavities of 9-day-old SPF embryonated chicken eggs. The presence of NDV particles in the allantoic fluid of inoculated eggs was confirmed using HA and HI assays with anti-CK/CH/LHeN/230/2011 chicken serum (17). The rescued viruses derived from plasmids pNDV-FJ28-F, pNDV-FJ28-FHN, pNDV-FJ28-FHN-ATG, pNDV-FJ28-FHN-CTA, pNDV-FJ28-FHN-ACG, PFJ28FL, PFJ28FL-ATG, PFJ28FL-CTA, PFJ28FL-1662, PFJ28FL-1674, PFJ28FL-1695, pNDV-ATA, and pNDV-CTA were named rLa-FJ28F, rLa-FJ28FHN, rLa-FJ28FHN-ATG, rLa-FJ28FHN-CTA, rLa-FJ28FHN-ACG, rFJ28, rFJ28-ATG, rFJ28-CTA, rFJ28-1662, rFJ28-1674, rFJ28-1695, rLaSota-ATA, and rLaSota-CTA, respectively.
After three successive passages in SPF embryonated chicken eggs, virus stocks of rescued viruses were prepared by inoculating 9-day-old SPF embryonated chicken eggs once, and the titers of the viruses were determined using the above-described method. Viral RNA was extracted from the stocks of recovered viruses, and the genome was amplified and sequenced as described above. The full-length genome of each recovered virus was sequenced and compared with that of the parental virus.
Pathogenicity index tests.
MDT in 9-day-old SPF embryonated chicken eggs and the ICPI in 1-day-old SPF chicks were used to evaluate the virulence of the NDVs as previously described (78). Both assays for each virus were performed three times.
Viral growth kinetics in ovo.
The growth kinetics of the NDVs in ovo were determined in SPF embryonated chicken eggs. First, 9-day-old SPF eggs were inoculated with 100 μL of 100 EID50 of the virus. Five eggs receiving each virus were harvested at 24, 48, 72, 96, and 120 hpi, and the viral titers were determined in SPF eggs using the above-described method.
Animal experiments and sample collection.
One hundred five 5-day-old SPF White Leghorn chicks were randomly divided into five groups of 21 birds each and housed in different isolators with negative pressure. Chicks in groups 1 to 4 were inoculated with rFJ28, rFJ28-ATG, LaSota, and rLaSota-ATA, respectively, via the oculonasal route, with a dose of 106 EID50/100 μL per chick. Birds in group 5 were inoculated with allantoic fluids. Clinical signs were investigated daily for all birds. Three birds from each group were killed humanely at 12, 24, 36, 48, 72, 96, and 120 hpi, and tissue samples of the Harderian gland, trachea, lung, spleen, cecal tonsil, and intestine were harvested and stored at −80°C until quantitative real-time RT-PCR analysis to measure the viral load.
Quantitation of viral load in tissue samples.
Viral loads in the tissue samples from rFJ28- and rFJ28-ATG-infected chicks were determined using a real-time RT-PCR method that was developed to detect class I NDVs, with a detection limit of 102.3 gene copies (9). Viral load in tissues from LaSota- and rLaSota-ATA-infected chicks were determined using another real-time RT-PCR method which targeted class II NDVs, with a detection limit of 102 gene copies (69). Briefly, viral RNA was extracted from homogenized tissue samples using TRIzol reagent (Invitrogen). The real-time RT-PCR was performed as previously described by us (44, 79, 80). Triplicate reactions were performed for each sample. Standard templates with known copy numbers and a negative template control (H2O) were included for quantitative analyses. Samples with a cycle threshold (CT) value above 35 were considered negative.
Flow cytometry.
DF-1 cells were infected with rFJ28, rFJ28-CTA, rFJ28-ATG, rFJ28-1662, rFJ28-1674, and rFJ28-1695 at an MOI of 1. After incubation, the virus inoculum was removed by washing three times with phosphate-buffered saline (PBS). Then, the cells were cultured in DMEM containing 5% FBS and 1 μg/mL TPCK-treated trypsin. At 24 hpi, the cells were collected from the wells using PBS containing 50 mM EDTA. Each cell sample was divided into two. One sample was used directly for subsequent analysis, and the other was permeabilized with 0.1% Triton X-100. After being washed with PBS, the cells were stained with an NDV F protein antibody (81) and incubated at 4°C for 1 h. The cells were washed with PBS and stained with fluorescein isothiocyanate (FITC)-labeled anti-mouse IgG antibody for 1 h at 4°C. After being washed with PBS and resuspended in PBS containing 1% bovine serum albumin (BSA), cells were subjected to flow cytometry analysis. The fluorescence of 10,000 cells was measured with a Cytomics TM FC 500 flow cytometer (Beckman Coulter, Fullerton, CA).
Statistical analysis.
GraphPad Prism software (GraphPad Software, La Jolla, CA, USA) was used for statistical analysis. Data are expressed as means and standard deviations (SD). The significance of differences between two groups was analyzed by Student’s t test. One-way analysis of variances with Bonferroni’s correction was employed for multigroup comparisons. The differences were considered significant if P values were <0.05.
Data availability.
The complete F gene coding sequences of the 232 isolates were deposited in GenBank under accession numbers MZ736900 to MZ737131 (Table S1). The complete genomic sequences of FJ28, FJ120, GX720, HeN325, and SH101 were deposited in GenBank with accession numbers MZ737132 to MZ737136.
ACKNOWLEDGMENTS
The allantoic fluids showing HA activity were kindly provided by Hualan Chen and Guohua Deng, Animal Influenza Laboratory of the Ministry of Agriculture, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences.
This work was supported by a National Natural Science Foundation of China Grant (31872504), a China Agriculture Research System grant (CARS-40-K18), and a Natural Science Foundation of Heilongjiang Province Grant (TD2021C001).
We declare that we have no conflict of interest.
Footnotes
Supplemental material is available online only.
Contributor Information
Shengwang Liu, Email: liushengwang@caas.cn.
Anice C. Lowen, Emory University School of Medicine
REFERENCES
- 1.Amarasinghe GK, Ayllón MA, Bào Y, Basler CF, Bavari S, Blasdell KR, Briese T, Brown PA, Bukreyev A, Balkema-Buschmann A, Buchholz UJ, Chabi-Jesus C, Chandran K, Chiapponi C, Crozier I, de Swart RL, Dietzgen RG, Dolnik O, Drexler JF, Dürrwald R, Dundon WG, Duprex WP, Dye JM, Easton AJ, Fooks AR, Formenty PBH, Fouchier RAM, Freitas-Astúa J, Griffiths A, Hewson R, Horie M, Hyndman TH, Jiāng D, Kitajima EW, Kobinger GP, Kondō H, Kurath G, Kuzmin IV, Lamb RA, Lavazza A, Lee B, Lelli D, Leroy EM, Lǐ J, Maes P, Marzano SL, Moreno A, Mühlberger E, Netesov SV, Nowotny N, et al. 2019. Taxonomy of the order Mononegavirales: update 2019. Arch Virol 164:1967–1980. 10.1007/s00705-019-04247-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Alexander DJ, Aldous EW, Fuller CM. 2012. The long view: a selective review of 40 years of Newcastle disease research. Avian Pathol 41:329–335. 10.1080/03079457.2012.697991. [DOI] [PubMed] [Google Scholar]
- 3.Dimitrov KM, Abolnik C, Afonso CL, Albina E, Bahl J, Berg M, Briand F-X, Brown IH, Choi K-S, Chvala I, Diel DG, Durr PA, Ferreira HL, Fusaro A, Gil P, Goujgoulova GV, Grund C, Hicks JT, Joannis TM, Torchetti MK, Kolosov S, Lambrecht B, Lewis NS, Liu H, Liu H, McCullough S, Miller PJ, Monne I, Muller CP, Munir M, Reischak D, Sabra M, Samal SK, Servan de Almeida R, Shittu I, Snoeck CJ, Suarez DL, Van Borm S, Wang Z, Wong FYK. 2019. Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virus. Infect Genet Evol 74:103917. 10.1016/j.meegid.2019.103917. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Diel DG, da Silva LH, Liu H, Wang Z, Miller PJ, Afonso CL. 2012. Genetic diversity of avian paramyxovirus type 1: proposal for a unified nomenclature and classification system of Newcastle disease virus genotypes. Infect Genet Evol 12:1770–1779. 10.1016/j.meegid.2012.07.012. [DOI] [PubMed] [Google Scholar]
- 5.Czeglédi A, Ujvári D, Somogyi E, Wehmann E, Werner O, Lomniczi B. 2006. Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications. Virus Res 120:36–48. 10.1016/j.virusres.2005.11.009. [DOI] [PubMed] [Google Scholar]
- 6.Miller PJ, Decanini EL, Afonso CL. 2010. Newcastle disease: evolution of genotypes and the related diagnostic challenges. Infect Genet Evol 10:26–35. 10.1016/j.meegid.2009.09.012. [DOI] [PubMed] [Google Scholar]
- 7.Dimitrov KM, Ramey AM, Qiu X, Bahl J, Afonso CL. 2016. Temporal, geographic, and host distribution of avian paramyxovirus 1 (Newcastle disease virus). Infect Genet Evol 39:22–34. 10.1016/j.meegid.2016.01.008. [DOI] [PubMed] [Google Scholar]
- 8.Kim LM, King DJ, Curry PE, Suarez DL, Swayne DE, Stallknecht DE, Slemons RD, Pedersen JC, Senne DA, Winker K, Afonso CL. 2007. Phylogenetic diversity among low-virulence newcastle disease viruses from waterfowl and shorebirds and comparison of genotype distributions to those of poultry-origin isolates. J Virol 81:12641–12653. 10.1128/JVI.00843-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kim LM, King DJ, Suarez DL, Wong CW, Afonso CL. 2007. Characterization of class I Newcastle disease virus isolates from Hong Kong live bird markets and detection using real-time reverse transcription-PCR. J Clin Microbiol 45:1310–1314. 10.1128/JCM.02594-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Seal BS, Wise MG, Pedersen JC, Senne DA, Alvarez R, Scott MS, King DJ, Yu Q, Kapczynski DR. 2005. Genomic sequences of low-virulence avian paramyxovirus-1 (Newcastle disease virus) isolates obtained from live-bird markets in North America not related to commonly utilized commercial vaccine strains. Vet Microbiol 106:7–16. 10.1016/j.vetmic.2004.11.013. [DOI] [PubMed] [Google Scholar]
- 11.Alexander DJ, Campbell G, Manvell RJ, Collins MS, Parsons G, McNulty MS. 1992. Characterisation of an antigenically unusual virus responsible for two outbreaks of Newcastle disease in the Republic of Ireland in 1990. Vet Rec 130:65–68. 10.1136/vr.130.4.65. [DOI] [PubMed] [Google Scholar]
- 12.Collins MS, Franklin S, Strong I, Meulemans G, Alexander DJ. 1998. Antigenic and phylogenetic studies on a variant Newcastle disease virus using anti-fusion protein monoclonal antibodies and partial sequencing of the fusion protein gene. Avian Pathol 27:90–96. 10.1080/03079459808419279. [DOI] [PubMed] [Google Scholar]
- 13.Gao S, Zhao Y, Yu J, Wang X, Zheng D, Cai Y, Liu H, Wang Z. 2019. Comparison between class I NDV and class II NDV in aerosol transmission under experimental condition. Poult Sci 98:5040–5044. 10.3382/ps/pez233. [DOI] [PubMed] [Google Scholar]
- 14.Fan S, Wang T, Gao X, Ying Y, Li X, Li Y, Li Y, Ma J, Sun H, Chu D, Xu Y, Yang S, Li Q, Gao Y, Xia X. 2015. Phylogenetic analysis of Newcastle disease viruses isolated from wild birds in the Poyang Lake region of China. J Vet Med Sci 77:1143–1149. 10.1292/jvms.14-0080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Liu X, Wang X, Wu S, Hu S, Peng Y, Xue F, Liu X. 2009. Surveillance for avirulent Newcastle disease viruses in domestic ducks (Anas platyrhynchos and Cairina moschata) at live bird markets in Eastern China and characterization of the viruses isolated. Avian Pathol 38:377–391. 10.1080/03079450903183637. [DOI] [PubMed] [Google Scholar]
- 16.Wang J, Lv Y, Zhang Y, Zheng D, Zhao Y, Castellan D, Liu H, Wang Z. 2016. Genomic characterizations of a Newcastle disease virus isolated from ducks in live bird markets in China. PLoS One 11:e0158771. 10.1371/journal.pone.0158771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wu W, Liu H, Zhang T, Han Z, Jiang Y, Xu Q, Shao Y, Li H, Kong X, Chen H, Liu S. 2015. Molecular and antigenic characteristics of Newcastle disease virus isolates from domestic ducks in China. Infect Genet Evol 32:34–43. 10.1016/j.meegid.2015.02.016. [DOI] [PubMed] [Google Scholar]
- 18.Ren S, Xie X, Wang Y, Tong L, Gao X, Jia Y, Wang H, Fan M, Zhang S, Xiao S, Wang X, Yang Z. 2016. Molecular characterization of a class I Newcastle disease virus strain isolated from a pigeon in China. Avian Pathol 45:408–417. 10.1080/03079457.2016.1153036. [DOI] [PubMed] [Google Scholar]
- 19.Wu C, Hu J, Ci X, Nie Y, Chen D, Zhang X, Chen W, Lin W, Xie Q. 2019. Molecular characterization, pathogenicity, and protection efficacy analysis of 2 wild-type lentogenic class I Newcastle disease viruses from chickens in China. Poult Sci 98:602–612. 10.3382/ps/pey471. [DOI] [PubMed] [Google Scholar]
- 20.Wu S, Wang W, Yao C, Wang X, Hu S, Cao J, Wu Y, Liu W, Liu X. 2011. Genetic diversity of Newcastle disease viruses isolated from domestic poultry species in Eastern China during 2005-2008. Arch Virol 156:253–261. 10.1007/s00705-010-0851-5. [DOI] [PubMed] [Google Scholar]
- 21.Dortmans JC, Koch G, Rottier PJ, Peeters BP. 2011. Virulence of Newcastle disease virus: what is known so far? Vet Res 42:122. 10.1186/1297-9716-42-122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Jin JH, Cheng JL, He ZR, Ren YC, Yu XH, Song Y, Yang HM, Yang YL, Liu T, Zhang GZ. 2017. Different origins of Newcastle disease virus hemagglutinin-neuraminidase protein modulate the replication efficiency and pathogenicity of the virus. Front Microbiol 8:1607. 10.3389/fmicb.2017.01607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Zhao W, Zhang Z, Zsak L, Yu Q. 2013. Effects of the HN gene C-terminal extensions on the Newcastle disease virus virulence. Virus Genes 47:498–504. 10.1007/s11262-013-0973-4. [DOI] [PubMed] [Google Scholar]
- 24.Qiu X, Fu Q, Meng C, Yu S, Zhan Y, Dong L, Song C, Sun Y, Tan L, Hu S, Wang X, Liu X, Peng D, Liu X, Ding C. 2016. Newcastle disease virus V protein targets phosphorylated STAT1 to block IFN-I signaling. PLoS One 11:e0148560. 10.1371/journal.pone.0148560. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Rout SN, Samal SK. 2008. The large polymerase protein is associated with the virulence of Newcastle disease virus. J Virol 82:7828–7836. 10.1128/JVI.00578-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Dortmans J, Rottier P, Koch G, Peeters B. 2010. The viral replication complex is associated with the virulence of Newcastle disease virus. J Virol 84:10113–10120. 10.1128/JVI.00097-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Peeters BP, de Leeuw OS, Koch G, Gielkens AL. 1999. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol 73:5001–5009. 10.1128/JVI.73.6.5001-5009.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Wang X, Dang R, Yang Z. 2019. The interferon antagonistic activities of the V proteins of NDV correlated with their virulence. Virus Genes 55:233–237. 10.1007/s11262-019-01637-3. [DOI] [PubMed] [Google Scholar]
- 29.Sun Y, Zheng H, Yu S, Ding Y, Wu W, Mao X, Liao Y, Meng C, Ur Rehman Z, Tan L, Song C, Qiu X, Wu F, Ding C. 2019. Newcastle disease virus V protein degrades mitochondrial antiviral signaling protein to inhibit host type I interferon production via E3 ubiquitin ligase RNF5. J Virol 93:e00322-19. 10.1128/JVI.00322-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Paldurai A, Kim SH, Nayak B, Xiao S, Shive H, Collins PL, Samal SK. 2014. Evaluation of the contributions of individual viral genes to newcastle disease virus virulence and pathogenesis. J Virol 88:8579–8596. 10.1128/JVI.00666-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Romer-Oberdorfer A, Veits J, Werner O, Mettenleiter TC. 2006. Enhancement of pathogenicity of Newcastle disease virus by alteration of specific amino acid residues in the surface glycoproteins F and HN. Avian Dis 50:259–263. 10.1637/7471-111505R.1. [DOI] [PubMed] [Google Scholar]
- 32.Heiden S, Grund C, Röder A, Granzow H, Kühnel D, Mettenleiter TC, Römer-Oberdörfer A. 2014. Different regions of the newcastle disease virus fusion protein modulate pathogenicity. PLoS One 9:e113344. 10.1371/journal.pone.0113344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Gould AR, Kattenbelt JA, Selleck P, Hansson E, Della-Porta A, Westbury HA. 2001. Virulent Newcastle disease in Australia: molecular epidemiological analysis of viruses isolated prior to and during the outbreaks of 1998-2000. Virus Res 77:51–60. 10.1016/s0168-1702(01)00265-9. [DOI] [PubMed] [Google Scholar]
- 34.Shengqing Y, Kishida N, Ito H, Kida H, Otsuki K, Kawaoka Y, Ito T. 2002. Generation of velogenic Newcastle disease viruses from a nonpathogenic waterfowl isolate by passaging in chickens. Virology 301:206–211. 10.1006/viro.2002.1539. [DOI] [PubMed] [Google Scholar]
- 35.Meng C, Qiu X, Yu S, Li C, Sun Y, Chen Z, Liu K, Zhang X, Tan L, Song C, Liu G, Ding C. 2016. Evolution of Newcastle disease virus quasispecies diversity and enhanced virulence after passage through chicken air sacs. J Virol 90:2052–2063. 10.1128/JVI.01801-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Yusoff K, Nesbit M, McCartney H, Meulemans G, Alexander DJ, Collins MS, Emmerson PT, Samson AC. 1989. Location of neutralizing epitopes on the fusion protein of Newcastle disease virus strain Beaudette C. J Gen Virol 70:3105–3109. 10.1099/0022-1317-70-11-3105. [DOI] [PubMed] [Google Scholar]
- 37.Toyoda T, Gotoh B, Sakaguchi T, Kida H, Nagai Y. 1988. Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization. J Virol 62:4427–4430. 10.1128/JVI.62.11.4427-4430.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Yu M, Wang E, Liu Y, Cao D, Jin N, Zhang CW, Bartlam M, Rao Z, Tien P, Gao GF. 2002. Six-helix bundle assembly and characterization of heptad repeat regions from the F protein of Newcastle disease virus. J Gen Virol 83:623–629. 10.1099/0022-1317-83-3-623. [DOI] [PubMed] [Google Scholar]
- 39.Stone-Hulslander J, Morrison TG. 1999. Mutational analysis of heptad repeats in the membrane-proximal region of Newcastle disease virus HN protein. J Virol 73:3630–3637. 10.1128/JVI.73.5.3630-3637.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Iorio RM, Glickman RL, Sheehan JP. 1992. Inhibition of fusion by neutralizing monoclonal antibodies to the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. J Gen Virol 73:1167–1176. 10.1099/0022-1317-73-5-1167. [DOI] [PubMed] [Google Scholar]
- 41.Iorio RM, Syddall RJ, Sheehan JP, Bratt MA, Glickman RL, Riel AM. 1991. Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition. J Virol 65:4999–5006. 10.1128/JVI.65.9.4999-5006.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Chambers P, Nesbit M, Yusoff K, Millar NS, Samson AC, Emmerson PT. 1988. Location of a neutralizing epitope for the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. J Gen Virol 69:2115–2122. 10.1099/0022-1317-69-8-2115. [DOI] [PubMed] [Google Scholar]
- 43.Hu S, Wang T, Liu Y, Meng C, Wang X, Wu Y, Liu X. 2010. Identification of a variable epitope on the Newcastle disease virus hemagglutinin-neuraminidase protein. Vet Microbiol 140:92–97. 10.1016/j.vetmic.2009.07.029. [DOI] [PubMed] [Google Scholar]
- 44.Sun J, Han Z, Qi T, Zhao R, Liu S. 2017. Chicken galectin-1B inhibits Newcastle disease virus adsorption and replication through binding to hemagglutinin-neuraminidase (HN) glycoprotein. J Biol Chem 292:20141–20161. 10.1074/jbc.M116.772897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Zhao R, Sun J, Qi T, Zhao W, Han Z, Yang X, Liu S. 2017. Recombinant Newcastle disease virus expressing the infectious bronchitis virus S1 gene protects chickens against Newcastle disease virus and infectious bronchitis virus challenge. Vaccine 35:2435–2442. 10.1016/j.vaccine.2017.03.045. [DOI] [PubMed] [Google Scholar]
- 46.Prévôt D, Darlix JL, Ohlmann T. 2003. Conducting the initiation of protein synthesis: the role of eIF4G. Biol Cell 95:141–156. 10.1016/s0248-4900(03)00031-5. [DOI] [PubMed] [Google Scholar]
- 47.Hernández G, Osnaya VG, Pérez-Martínez X. 2019. Conservation and variability of the AUG initiation codon context in eukaryotes. Trends Biochem Sci 44:1009–1021. 10.1016/j.tibs.2019.07.001. [DOI] [PubMed] [Google Scholar]
- 48.Noton SL, Fearns R. 2015. Initiation and regulation of paramyxovirus transcription and replication. Virology 479-480:545–554. 10.1016/j.virol.2015.01.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Chen L, Song J, Liu H, Cai J, Lin Q, Xu C, Ding C, Liao M, Ren T, Xiang B. 2021. Phylodynamic analyses of class I Newcastle disease virus isolated in China. Transbound Emerg Dis 68:1294–1304. 10.1111/tbed.13785. [DOI] [PubMed] [Google Scholar]
- 50.Zhang P, Xie G, Liu X, Ai L, Chen Y, Meng X, Bi Y, Chen J, Sun Y, Stoeger T, Ding Z, Yin R. 2015. High genetic diversity of Newcastle disease virus in wild and domestic birds in northeastern China from 2013 to 2015 reveals potential epidemic trends. Appl Environ Microbiol 82:1530–1536. 10.1128/AEM.03402-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Zhu J, Xu H, Liu J, Zhao Z, Hu S, Wang X, Liu X. 2014. Surveillance of avirulent Newcastle disease viruses at live bird markets in Eastern China during 2008-2012 reveals a new sub-genotype of class I virus. Virol J 11:211. 10.1186/s12985-014-0211-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Tian Y, Xue R, Yang W, Li Y, Xue J, Zhang G. 2020. Characterization of ten paramyxovirus type 1 viruses isolated from pigeons in China during 1996-2019. Vet Microbiol 244:108661. 10.1016/j.vetmic.2020.108661. [DOI] [PubMed] [Google Scholar]
- 53.Wang J, Liu H, Liu W, Zheng D, Zhao Y, Li Y, Wang Y, Ge S, Lv Y, Zuo Y, Yu S, Wang Z. 2015. Genomic characterizations of six pigeon paramyxovirus type 1 viruses isolated from live bird markets in China during 2011 to 2013. PLoS One 10:e0124261. 10.1371/journal.pone.0124261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Afonso CL. 2021. Virulence during Newcastle disease viruses cross species adaptation. Viruses 13:110. 10.3390/v13010110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Lu X, Wang X, Zhan T, Sun Y, Wang X, Xu N, Liao T, Chen Y, Gu M, Hu S, Liu X, Liu X. 2021. Surveillance of class I Newcastle disease virus at live bird markets and commercial poultry farms in eastern China reveals the epidemic characteristics. Virol Sin 36:818–822. 10.1007/s12250-021-00357-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Huovilainen A, Ek-Kommone C, Manvell R, Kinnunen L. 2001. Phylogenetic analysis of avian paramyxovirus 1 strains isolated in Finland. Arch Virol 146:1775–1785. 10.1007/s007050170063. [DOI] [PubMed] [Google Scholar]
- 57.Jørgensen PH, Handberg KJ, Ahrens P, Therkildsen OR, Manvell RJ, Alexander DJ. 2004. Strains of avian paramyxovirus type 1 of low pathogenicity for chickens isolated from poultry and wild birds in Denmark. Vet Rec 154:497–500. 10.1136/vr.154.16.497. [DOI] [PubMed] [Google Scholar]
- 58.Xiang B, Han L, Gao P, You R, Wang F, Xiao J, Liao M, Kang Y, Ren T. 2017. Spillover of Newcastle disease viruses from poultry to wild birds in Guangdong province, southern China. Infect Genet Evol 55:199–204. 10.1016/j.meegid.2017.09.020. [DOI] [PubMed] [Google Scholar]
- 59.Chambers P, Millar NS, Emmerson PT. 1986. Nucleotide sequence of the gene encoding the fusion glycoprotein of Newcastle disease virus. J Gen Virol 67:2685–2694. 10.1099/0022-1317-67-12-2685. [DOI] [PubMed] [Google Scholar]
- 60.Martoglio B, Dobberstein B. 1998. Signal sequences: more than just greasy peptides. Trends Cell Biol 8:410–415. 10.1016/s0962-8924(98)01360-9. [DOI] [PubMed] [Google Scholar]
- 61.Shao J, Liu X, Ly H, Liang Y. 2016. Characterization of the glycoprotein stable signal peptide in mediating Pichinde virus replication and virulence. J Virol 90:10390–10397. 10.1128/JVI.01154-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Eichler R, Lenz O, Strecker T, Garten W. 2003. Signal peptide of Lassa virus glycoprotein GP-C exhibits an unusual length. FEBS Lett 538:203–206. 10.1016/s0014-5793(03)00160-1. [DOI] [PubMed] [Google Scholar]
- 63.Lindemann D, Pietschmann T, Picard-Maureau M, Berg A, Heinkelein M, Thurow J, Knaus P, Zentgraf H, Rethwilm A. 2001. A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J Virol 75:5762–5771. 10.1128/JVI.75.13.5762-5771.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Chou MM, Kendall DA. 1990. Polymeric sequences reveal a functional interrelationship between hydrophobicity and length of signal peptides. J Biol Chem 265:2873–2880. 10.1016/S0021-9258(19)39882-5. [DOI] [PubMed] [Google Scholar]
- 65.Eichler R, Lenz O, Strecker T, Eickmann M, Klenk HD, Garten W. 2004. Lassa virus glycoprotein signal peptide displays a novel topology with an extended endoplasmic reticulum luminal region. J Biol Chem 279:12293–12299. 10.1074/jbc.M312975200. [DOI] [PubMed] [Google Scholar]
- 66.Hikita C, Mizushima S. 1992. Effects of total hydrophobicity and length of the hydrophobic domain of a signal peptide on in vitro translocation efficiency. J Biol Chem 267:4882–4888. 10.1016/S0021-9258(18)42913-4. [DOI] [PubMed] [Google Scholar]
- 67.Du J, Xia J, Li S, Shen Y, Chen W, Luo Y, Zhao Q, Wen Y, Wu R, Yan Q, Huang X, Cao S, Han X, Cui M, Huang Y. 2020. Evolutionary dynamics and transmission patterns of Newcastle disease virus in China through Bayesian phylogeographical analysis. PLoS One 15:e0239809. 10.1371/journal.pone.0239809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Deng G, Tan D, Shi J, Cui P, Jiang Y, Liu L, Tian G, Kawaoka Y, Li C, Chen H. 2013. Complex reassortment of multiple subtypes of avian influenza viruses in domestic ducks at the Dongting Lake region of China. J Virol 87:9452–9462. 10.1128/JVI.00776-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Wise MG, Suarez DL, Seal BS, Pedersen JC, Senne DA, King DJ, Kapczynski DR, Spackman E. 2004. Development of a real-time reverse-transcription PCR for detection of newcastle disease virus RNA in clinical samples. J Clin Microbiol 42:329–338. 10.1128/JCM.42.1.329-338.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27:493–497. 10.1093/oxfordjournals.aje.a118408. [DOI] [Google Scholar]
- 71.Liu X, Shao Y, Ma H, Sun C, Zhang X, Li C, Han Z, Yan B, Kong X, Liu S. 2013. Comparative analysis of four Massachusetts type infectious bronchitis coronavirus genomes reveals a novel Massachusetts type strain and evidence of natural recombination in the genome. Infect Genet Evol 14:29–38. 10.1016/j.meegid.2012.09.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Ma T, Xu L, Ren M, Shen J, Han Z, Sun J, Zhao Y, Liu S. 2019. Novel genotype of infectious bronchitis virus isolated in China. Vet Microbiol 230:178–186. 10.1016/j.vetmic.2019.01.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Meng C, Qiu X, Jin S, Yu S, Chen H, Ding C. 2012. Whole genome sequencing and biological characterization of Duck/JS/10, a new lentogenic class I Newcastle disease virus. Arch Virol 157:869–880. 10.1007/s00705-012-1248-4. [DOI] [PubMed] [Google Scholar]
- 74.Xu Q, Sun J, Gao M, Zhao S, Liu H, Zhang T, Han Z, Kong X, Liu S. 2017. Genetic, antigenic, and pathogenic characteristics of Newcastle disease viruses isolated from geese in China. J Vet Diagn Invest 29:489–498. 10.1177/1040638717709855. [DOI] [PubMed] [Google Scholar]
- 75.Burland TG. 2000. DNASTAR's Lasergene sequence analysis software. Methods Mol Biol 132:71–91. [DOI] [PubMed] [Google Scholar]
- 76.Kearse M, Moir R, Wilson A, Stones-Havas S, Cheung M, Sturrock S, Buxton S, Cooper A, Markowitz S, Duran C, Thierer T, Ashton B, Meintjes P, Drummond A. 2012. Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28:1647–1649. 10.1093/bioinformatics/bts199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Kumar S, Stecher G, Li M, Knyaz C, Tamura K. 2018. MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. Mol Biol Evol 35:1547–1549. 10.1093/molbev/msy096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Alexander D. 2000. Newcastle disease and other avian paramyxoviruses. Rev Sci Tech 19:443–462. 10.20506/rst.19.2.1231. [DOI] [PubMed] [Google Scholar]
- 79.Sun J, Han Z, Shao Y, Cao Z, Kong X, Liu S. 2014. Comparative proteome analysis of tracheal tissues in response to infectious bronchitis coronavirus, Newcastle disease virus, and avian influenza virus H9 subtype virus infection. Proteomics 14:1403–1423. 10.1002/pmic.201300404. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Sun J, Han Z, Zhao R, Ai H, Chen L, Li L, Liu S. 2020. Protection of chicks from Newcastle disease by combined vaccination with a plasmid DNA and the pre-fusion protein of the virulent genotype VII of Newcastle disease virus. Vaccine 38:7337–7349. 10.1016/j.vaccine.2020.09.039. [DOI] [PubMed] [Google Scholar]
- 81.Shao Y, Sun J, Han Z, Liu S. 2018. Recombinant infectious laryngotracheitis virus expressing Newcastle disease virus F protein protects chickens against infectious laryngotracheitis virus and Newcastle disease virus challenge. Vaccine 36:7975–7986. 10.1016/j.vaccine.2018.11.008. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Fig. S1 and S2 and Tables S1 to S4. Download jvi.00241-22-s0001.pdf, PDF file, 3.0 MB (3MB, pdf)
Data Availability Statement
The complete F gene coding sequences of the 232 isolates were deposited in GenBank under accession numbers MZ736900 to MZ737131 (Table S1). The complete genomic sequences of FJ28, FJ120, GX720, HeN325, and SH101 were deposited in GenBank with accession numbers MZ737132 to MZ737136.




